This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 55
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Systolic Hypertension is a disorder which is characterized by significant elevations in systolic blood pressure in association with normal diastolic blood pressure. Typically, this develops in individuals >50 years of age and is associated with an increased risk of stroke and myocardial infarction. While there are many effective therapies for essential/diastolic hypertension, the treatment of systolic hypertension is complicated by side effects from traditional therapies. This limits therapeutic options and has resulted in a number of at-risk individuals being left untreated. We are conducting a randomized, controlled trial (n=90) to compare the effects of two different stress management training on blood pressure. The primary outcome is change in systolic blood pressure and pulse pressure. Secondary outcomes are changes in nitric oxide, stress hormones and psychological well-being. Additional analyses will be conducted to assess for other confounding effects on BP and PP.

Provided treatments

  • Behavioral: Stress Management Training
  • Behavioral: Stress Management Training
Tris trial is registered with FDA with number: NCT00913991. The sponsor of the trial is National Center for Complementary and Integrative Health (NCCIH) and it is looking for 90 volunteers for the current phase.
Official trial title:
Mechanisms of the Relaxation Response in Elderly Hypertensives